PAHC (Phibro Animal Health Corporation Class A)
Insider Trading Activity
Every open-market purchase and sale reported by PAHC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Larry Lee Miller | Chief Operating Officer | A | — | — |
| 2026-09-17 | Glenn David | Chief Financial Officer | A | — | — |
| 2026-08-10 | Patrick Rodriguez | VP Finance and Treasurer | A | — | — |
| 2026-08-10 | Jonathan BENDHEIM | Director | A | — | — |
| 2026-08-10 | Lisa Ann Escudero | See Remarks | A | — | — |
| 2026-08-10 | BFI Co., LLC | 10%+ Owner | A | — | — |
| 2026-08-10 | Daniel M Bendheim | President and CEO | A | — | — |
| 2026-08-10 | Glenn David | Chief Financial Officer | A | — | — |
| 2026-08-10 | Larry Lee Miller | Chief Operating Officer | A | — | — |
| 2026-08-10 | Judith Weinstein | See Remarks | A | — | — |
| 2026-08-06 | Judith Weinstein | See Remarks | J | — | — |
| 2026-08-06 | Glenn David | Chief Financial Officer | J | — | — |
| 2026-08-06 | Lisa Ann Escudero | See Remarks | J | — | — |
| 2026-08-06 | Daniel M Bendheim | President and CEO | J | — | — |
| 2026-08-06 | Larry Lee Miller | Chief Operating Officer | J | — | — |
| 2026-08-06 | JACK BENDHEIM | Executive Chairman | J | — | — |
| 2026-08-06 | Larry Lee Miller | Chief Operating Officer | J | — | — |
| 2026-08-06 | Judith Weinstein | See Remarks | J | — | — |
| 2026-08-06 | Daniel M Bendheim | President and CEO | J | — | — |
| 2026-08-06 | Glenn David | Chief Financial Officer | J | — | — |
| 2026-08-06 | Lisa Ann Escudero | See Remarks | J | — | — |
| 2026-08-06 | BFI Co., LLC | 10%+ Owner | J | — | — |
| 2026-07-02 | Daniel M Bendheim | President and CEO | A | — | — |
| 2026-06-02 | E THOMAS CORCORAN | Director | Buy | — | — |
| 2026-05-07 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2026-04-23 | JACK BENDHEIM | President and CEO | Sell | — | — |
| 2026-04-16 | JACK BENDHEIM | President and CEO | MIXED | — | — |
| 2026-03-26 | JACK BENDHEIM | President and CEO | Sell | — | — |
| 2026-03-19 | JACK BENDHEIM | President and CEO | Sell | — | — |
| 2026-03-16 | BFI Co., LLC | 10%+ Owner | MIXED | — | — |
| 2026-02-26 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2026-02-23 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2026-02-18 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2026-02-11 | Glenn David | Chief Financial Officer | MIXED | — | — |
| 2026-02-11 | JACK BENDHEIM | President and CEO | Sell | — | — |
| 2026-02-09 | JACK BENDHEIM | President and CEO | MIXED | — | — |
| 2026-02-05 | BFI Co., LLC | 10%+ Owner | MIXED | — | — |
| 2026-02-02 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2026-01-27 | JACK BENDHEIM | President and CEO | MIXED | — | — |
| 2026-01-22 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2026-01-15 | JACK BENDHEIM | President and CEO | MIXED | — | — |
| 2026-01-13 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2026-01-08 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2025-12-15 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2025-12-10 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2025-12-04 | JACK BENDHEIM | President and CEO | MIXED | — | — |
| 2025-12-02 | BFI Co., LLC | 10%+ Owner | Sell | — | — |
| 2025-11-26 | JACK BENDHEIM | President and CEO | Sell | — | — |
| 2025-11-24 | JACK BENDHEIM | President and CEO | Sell | — | — |
| 2025-11-18 | BFI Co., LLC | 10%+ Owner | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 1,727,748 | — |
| — | 10%+ Owner | 82,792 | — |
| — | Executive Chairman | 70,689 | — |
| — | Chief Financial Officer | 54,959 | — |
| — | Director | 41,459 | — |
| — | Chief Operating Officer | 38,275 | — |
| — | Pres Animal Health & Nutr N.A. | 21,560 | — |
| — | President and CEO | 15,177 | — |
| — | Director | 5,984 | — |
| — | See Remarks | 5,453 | — |
| — | Sr VP, Human Resources | 5,000 | — |
| — | See Remarks | 3,434 | — |
| — | See Remarks | 1,793 | — |
| — | VP Finance and Treasurer | 1,503 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PAHC quote page; the site-wide leaderboard is on the insider transactions hub.